Last $2.69 USD
Change Today -0.01 / -0.37%
Volume 970.7K
CTIC On Other Exchanges
Symbol
Exchange
BrsaItaliana
NASDAQ CM
Frankfurt
As of 5:20 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Richard E. Leigh Jr.

Former Executive Vice President and General Counsel, CTI BioPharma Corp.
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 2 different industries.

See Board Relationships
54--

Background*

Mr. Richard E. Leigh, Jr., served as Senior Vice President, Corporate Secretary and General Counsel of Motricity Inc. from September 2008 to August 2011. Mr. Leigh served as an Executive Vice President and General Counsel of Cell Therapeutics Inc. from August 2004 to 2005 and served as its Secretary. He served as a member of Cell Therapeutics Inc.'s senior management team oversaw all legal matters related to the organization including intellectual property and corporate ...

Read Full Background

Corporate Headquarters*

3101 Western Avenue
Seattle, Washington 98121

United States

Phone: 206-282-7100
Fax: 206-284-6206

Board Members Memberships*

Trustee

Education*

BA
Brown University
MA
Paul H Nitze School of Advanced International Studies
JD
School Of Law, Columbia University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CTIC:US $2.69 USD -0.01

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$528.2K
Robert I. Blum Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern
Cytokinetics, Incorporated
$555.0K
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
$1.1M
James M. Gower Chairman, Chief Executive Officer and Member of Finance Committee
Rigel Pharmaceuticals, Inc.
$695.1K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CTI BIOPHARMA CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.